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Wild-type strains of Escherichia coli are unable to utilize aromatic -glucosides such as arbutin and salicin
because the major genetic system that encodes the functions for their catabolism, the bgl operon, is silent and
uninducible. We show that strains that carry an activated bgl operon exhibit a growth advantage over the wild
type in stationary phase in the presence of the rpoS819 allele that causes attenuated rpoS regulon expression.
Our results indicate a possible evolutionary advantage in retaining the silent bgl operon by wild-type bacteria.
In Escherichia coli, the primary genes involved in the uptake
and utilization of the aryl--glucosides salicin and arbutin are
encoded by the bgl operon (22). The operon comprises three
genes, bglG, bglF, and bglB (18, 28). BglG is a positive regula-
tor of the operon acting as an antiterminator, BglF is the
bgl-specific component of the phosphotransferase that is also a
negative regulator of the operon, and BglB is the phospho--
glucosidase responsible for cleaving the phosphorylated sub-
strate. The bglR locus comprises the promoter and other cis-
regulatory elements. Most wild-type strains are phenotypically
Bgl, as the bgl genes are not transcribed even in the presence
of aryl--glucosides. Various cis-acting elements that include
DNA structural elements and trans-acting factors, such as the
global regulator H-NS, are responsible for the silencing of the bgl
promoter (16, 20, 25, 26, 31). However, Bgl mutants arise spon-
taneously in the population at a detectable frequency (6, 9, 13, 23,
24, 29, 33). Once activated, bgl expression is specifically regulated
by aryl--glucosides (1, 2, 3, 17, 27) and is subject to catabolite
control (10, 11).
The fact that the bgl operon, in spite of being silent, has been
maintained without accumulating deleterious mutations is in-
triguing. One explanation for the retention of such cryptic
genes by the organism is that these genes, although silent
under the conditions of observation, may be expressed under
specific physiological conditions, providing a selective advan-
tage to the organism (21). Thus, it is worthwhile to explore
different physiological conditions that could affect the expres-
sion of such cryptic genes and thereby gain insights into their
evolutionary significance. In the present study, an attempt has
been made in this direction with regard to the bgl operon of
E. coli.
Microorganisms such as E. coli undergo rapid evolution dur-
ing prolonged incubation in stationary phase (35). Under these
conditions, while the majority of the population dies, a small
minority can grow and take over the culture (7, 8, 34, 35).
These survivors carry mutations that confer a growth advan-
tage in stationary phase, or GASP. GASP is a continuous
phenomenon, i.e., during prolonged incubation in stationary
phase, various population takeovers occur as different mutants
with increased fitness outgrow the rest of the population (7,
35). As the cultures age, they increase in diversity as several
genetically distinct subpopulations coexist. The first GASP mu-
tations identified were in the rpoS locus. The rpoS gene prod-
uct is an alternative sigma factor, which regulates the expres-
sion of several genes involved in stress response during
stationary phase (12, 14, 15, 30, 32). One of the well-charac-
terized rpoS mutations that confers the GASP phenotype is the
rpoS819 allele that has a 46-bp duplication at the 3 end of the
gene, causing a frameshift that replaces the last four amino
acids with 39 new residues, resulting in attenuated rpoS regu-
lon expression (35). Only rpoS mutations that result in atten-
uated expression and not deletions are known to confer the
GASP phenotype. The exact physiological basis for the GASP
phenotype of strains that harbor the rpoS819 allele is not
clearly understood, but the strains are able to grow faster in the
presence of certain amino acids (36).
The present study was undertaken to investigate the possible
role of the bgl operon in conferring a GASP phenotype. Here,
we show that mutants that harbor an activated bgl operon
accumulate among the survivors of prolonged starvation and
that an activated bgl operon confers a growth advantage to the
organism in stationary phase in strains that carry the rpoS819
allele.
MATERIALS AND METHODS
Bacterial strains. The E. coli strains used in this study are shown in Table 1.
Media and growth conditions. Cells were grown in Luria broth with aeration
at 37°C. For long-term cultures, the tubes were topped up with sterile distilled
water to compensate for evaporation whenever necessary. Antibiotics were
added at the following concentrations: tetracycline (15 g/ml), kanamycin (50
g/ml), streptomycin (25 g/ml), and nalidixic acid (20 g/ml).
Mixed cultures. Cultures were grown in 3 ml of Luria broth in glass test tubes
under aeration at 37°C in a New Brunswick shaker. Mixed cultures were started
after 24 h of growth by transference of appropriate volumes of the two cultures
in a fresh tube with a total final volume of 3 ml. The titers of the cultures were
determined by plating different dilutions on LB plates containing the appro-
priate antibiotics. Markers used to distinguish the strains in mixed cultures
(either for streptomycin resistance and nalidixic acid resistance or for tetra-
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cycline resistance and kanamycin resistance) were found to be neutral in our
experimental conditions.
Genetic manipulations. Phage P1 transduction was performed as described by
Miller (19).
Construction of the bgl deletion strain. The bgl deletion was created using the
procedure of Datsenko and Wanner (5). Hybrid primers with 36-bp extensions
homologous to the bgl sequences spanning positions 110 (bglR) and 3920
(bglB) were designed for the template plasmid pKD4 carrying the kanamycin
resistance gene that is flanked by FLP recognition target sites (forward primer,
5 ATATAACTTTATAAATTCCTAAAATTACACAAAGTTGTGTAGGCT
GGAGCTGCTTCG 3; reverse primer, 5 AATGCTTTCGTCGTGGGAAAC
ACAACCAGTCATGTACATATGAATATCCTCCTTA 3]. The PCR product
generated using the primers carried a deletion of bglR, bglG, bglF, and a large
segment of bglB. The deleted sequences were replaced by the kanamycin resis-
tance gene. The deletion was recombined at the bgl locus in the strain ZK819-
97T using the helper plasmid pKD46 expressing the phage lambda red recom-
binase, with kanamycin resistance serving as a selectable marker. The resistance
gene was then eliminated using the helper plasmid pCP20 that expresses the FLP
recombinase, leaving a scar of about 80 bp at the bgl locus. The 80-bp sequence
carries an ideal ribosome binding site and an initiation codon to eliminate polar
effects on downstream sequences. The deletion was confirmed by PCR analysis
and the inability of the strain to papillate to Bgl.
Construction of the bglBmutant strain carrying a disruption of bglB. The bglB
mutant strain was created using the same procedure described above. Hybrid
primers with a 36-bp extension homologous to the sequences spanning positions
314 and 315 of the bglB open reading frame were designed for the template
plasmid pKD3 carrying a chloramphenicol resistance gene that is flanked by FLP
recognition target sites (forward primer, 5 CGACGAAGTCGAACCGAATGA
AGCGGGGTTAGCGTTGTGTAGGCTGGAGCTGCTTCG 3; reverse primer,
5 CCCGCCTGCGCCATTTCATCAAACAGCCGATCGTAACATATGAA
TATCCTCCTTA 3). The PCR product generated was used to disrupt the bglB
gene in the strain ZK819-97T. The resistance gene was then eliminated, leaving
an 80-bp scar that disrupts the 5 end of the bglB gene after residue 104. The
disruption was confirmed by PCR analysis, the strain’s Arb Sal status, and its
inability to papillate to Sal on MacConkey-salicin medium.
RESULTS
Bgl mutants are found among the survivors present in
28-day-old cultures. One hundred and fifty survivors from 10
Luria broth cultures of the strain ZK819 maintained at 37°C
for 28 days with aeration were randomly chosen for analysis.
Of these, five isolates were found to be Bgl. In four of the five
Bgl isolates, namely, ZK819-66, ZK819-67, ZK819-71, and
ZK819-73, all obtained from the same culture, the activating
mutation was in the hns locus, as indicated by their phenotypic
reversion to the Bglstate in the presence of a plasmid carrying
the wild-type hns gene. The remaining Bgl isolate, ZK819-97,
was Bgl even in the presence of the hns plasmid, suggesting
that the mutation was not within hns. Transduction using P1
phage grown on a strain carrying a Tn10 transposon within the
tna locus (80% linked to the bgl operon) indicated that the
activating mutation in ZK819-97 is linked to the bgl operon.
The bgl regulatory region in ZK819-97 was amplified by PCR
to determine the nature of the activating mutation. The size of the
fragment obtained was similar to that of the wild-type parent
strain, indicating the absence of insertion sequences within the
regulatory region, which is a common activating mutation. Nu-
cleotide sequence analysis of the regulatory region revealed the
presence of a point mutation, a C-to-T transition, at the cyclic
AMP (cAMP) receptor protein (CRP)-cAMP binding site in the
regulatory region of the operon. This transition, which brings the
site closer to the CRP binding consensus sequence, is known to
activate the bgl operon (16, 24). Up to now, this point mutation
has been only rarely observed among natural Bgl isolates and
has normally been obtained only after mutagenesis.
FIG. 1. Competition experiments between ZK819-97 (Bgl) () and ZK820 (Bgl) (■). One-day-old cultures of the two strains were mixed
in ratios of 1:1,000 (A) and 1,000:1 (B).
TABLE 1. E. coli strains used in this study
Strain Relevantgenotype or phenotype
Reference
or source
ZK819 ZK126 rpoS819
(Strr Bgl)
35
ZK820 ZK126 rpoS819
(Nalr Bgl)
35
ZK819-97 ZK819 bglR (Bgl) This study
ZK819-97T ZK819 tna::Tn10 bglR
(Bgl)
This study
ZK819-97bgl ZK819-97T bglRGFB
(Bgl)
This study
ZK819-97B ZK819-97T bglB104
(Sal Arb)
This study
ZK819Tn10 ZK819 Tetr This study
ZK819Tn5 ZK819 Kanr This study
AE328 RV tna::Tn10 bglR::IS1
(Bgl)
A. Wright
MG RpoS Cmr MG1655 rpoS Cmr J. Gowrishankar
ZK819-IS1 ZK819 tna::Tn10 bglR::IS1
(Bgl)
This study
ZK819 Tn5
RpoS
ZK819 Tn5 rpoS Cmr This study
ZK819-97T
RpoS
ZK819-97T rpoS Cmr This study
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The Bgl strain ZK819-97 shows a GASP phenotype when
competed against the parent. As the Bgl strain ZK819-97 is a
survivor of prolonged starvation, it is conceivable that the
strain exhibits a GASP phenotype. To test this possibility,
ZK819-97 was competed against the Bglstrain, ZK820, which
is isogenic to the parent strain ZK819 but carries a different
antibiotic resistance marker. These studies showed that the
Bgl strain was able to take over the culture in stationary
phase even when it was initially present in a minority (Fig. 1).
ZK819-97 is likely to carry other mutations in addition to the
one responsible for its Bgl phenotype. To determine whether
the GASP phenotype is related to the Bgl status, the bgl allele
from ZK819-97 was transferred by P1 transduction to its pa-
rental strain, ZK819, using the Tn10 transposon within tna that
is linked to the bgl operon. The resulting strain, ZK819-97T,
thus is isogenic to the parental strain ZK819, except for con-
taining an activated bgl allele. To determine whether the acti-
vated bgl allele in this strain confers upon it the GASP phe-
notype, competition experiments were carried out between
ZK819-97T carrying the transposon Tn10 and the parent
(Bgl) strain ZK819 carrying the transposon Tn5. The trans-
poson insertions were used as selective markers and were
shown to be neutral in control experiments. The Bgl strain
was mixed with the parent strain in different ratios, and the
FIG. 2. Competition experiments between ZK819-97T (Bgl) () and ZK819Tn5 (Bgl] (■). One-day-old cultures of the two strains were
mixed in ratios of 1:1,000 (A) and 1,000:1 (B).
FIG. 3. (A and B) Competition assays of ZK819-97bgl () with the wild-type strain ZK819Tn5 (■). One-day-old cultures of two strains were
mixed in ratios of 1:1,000 (A) and 1,000:1 (B). (C and D) Competition assays of ZK819-97B () with the wild-type strain ZK819Tn5 (■).
One-day-old cultures of two strains were mixed in ratios of 1:1,000 (C) and 1,000:1 (D).
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population numbers of the two strains were followed during
prolonged incubation in stationary phase. One-day-old cul-
tures of the two strains grown in LB were mixed reciprocally at
a 1:1,000 ratio, and the populations were monitored by viable
count assay. Each competition was performed at least four
times. Results from representative mixtures are shown in
Fig. 2. As can be seen from the results, the Bgl strain, when
added as a minority in the mixed cultures, was able to grow and
in about 4 days reach numbers that nearly equal those of the
Bglstrain. When the Bglstrain was added in the minority, its
viable counts did not increase. These results indicate a growth
advantage for the Bgl strain compared to its parent.
Deletion of the bgl locus from the Bgl strain results in the
loss of the fitness advantage. For the competition experiments
between Bgl and Bglstrains, the activated bgl allele was
transduced from the Bgl survivor ZK819-97 to its parental
strain ZK819 by means of P1 transduction. During P1 trans-
duction, a large fragment of DNA (about 90 kb) was trans-
ferred to the recipient that may include additional mutations.
To associate the GASP phenotype of the strain ZK819-97T
specifically with its activated bgl allele, the bgl locus was deleted
from ZK819-97T. If the GASP phenotype of ZK819-97T is
associated with the activated bgl allele, deletion of the bgl locus
should result in the loss of its GASP phenotype. To test this, a
deletion of the bgl locus in ZK819-97T was constructed using
the lambda red recombination system (5). This strain, ZK819-
97bgl, was competed against ZK819. As shown in Fig. 3A, the
strain ZK819-97T lost the GASP phenotype when the bgl locus
was deleted, indicating that the GASP phenotype is specifically
associated with the activated bgl allele.
Disruption of the bglB locus in the Bgl strain results in the
loss of the GASP phenotype. To test whether the -glucosidase
function encoded by the bglB gene of the bgl operon is essential
for the GASP phenotype of the strain ZK819-97T, the bglB
gene was disrupted in this strain. The resulting strain was
unable to utilize salicin due to the absence of BglB, although it
was still capable of utilizing arbutin, as the constitutive bglA
locus was present in the strain. This strain, ZK819-97B, was
competed against ZK819. As shown in Fig. 3B, the strain
ZK819-97TB in which the bglB locus was disrupted lost the
GASP phenotype, indicating that a functional BglB is required
for the GASP phenotype.
The GASP phenotype of Bgl strains is independent of the
nature of the activating mutation. The activating mutation in
the strain ZK819-97T is a point mutation within the CRP-
cAMP binding site. The more commonly seen mutations that
activate the bgl operon are insertions of IS1 and IS5 in bglR,
upstream of the promoter. To determine if the GASP pheno-
type of ZK819-97T is related to the specific bgl allele, the bgl
operon from a strain carrying an activating IS1 insertion in
bglR was transduced into ZK819. The resulting Bgl strain,
ZK819-IS1, was competed against the parent ZK819. These
results, shown in Fig. 4, indicate that the activation of the bgl
operon by IS1 also confers a GASP phenotype to the strain.
FIG. 4. Competition assays of ZK819-IS1 () with ZK819Tn5 (■). One-day-old-cultures of the two strains were mixed in ratios of 1:1,000 (A) and
1,000:1 (B).
FIG. 5. Competition assays of ZK819-97TRpoS () with ZK819Tn5RpoS (■). One-day-old-cultures of two strains were mixed in ratios of
1:1,000 (A) and 1,000:1 (B).
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The rpoS819 allele is necessary for the GASP phenotype con-
ferred by bgl activation. In the experiments described above, the
activated bgl allele was always associated with the rpoS819
allele that can independently confer a GASP phenotype. To
test whether the GASP phenotype of ZK819-97T can persist in
the absence of the rpoS819 allele, the wild-type rpoS allele was
transduced into ZK819-97T. The resulting strain, ZK819-
97TRpoS, failed to show the GASP phenotype when com-
peted against the Bgl rpoS parent (Fig. 5). These results
indicate that the selective advantage conferred by the Bgl
state in stationary phase requires the presence of the rpoS819
mutation.
DISCUSSION
The retention of cryptic genes such as the bgl operon, with-
out the accumulation of deleterious mutations, remains an
evolutionary puzzle. Here, we have shown that Bgl mutants
were found among the survivors of prolonged incubation in
stationary phase; these strains exhibited the GASP phenotype
compared to their parent. These results suggest that expression
of the bgl genes confers a fitness advantage during stationary
phase. Interestingly, this advantage manifests only in the pres-
ence of the rpoS819 allele that has been shown to be a strong
GASP locus (35). Though the mechanism involved in the
growth advantage conferred by the rpoS819 allele is unknown,
one possibility is that the mutation provides additional meta-
bolic capabilities (36). The activation of the bgl genes may help
augment this capability.
The precise physiological reasons for the advantage con-
ferred by the activated bgl allele under these conditions are not
clear at present. The growth medium used in these studies is
LB with no added aryl--glucosides. However, it is possible
that the debris from the dying cells, such as the breakdown
products of the peptidoglycan cell wall, contains -glucosides
that provide a catabolizable source of energy. The loss of the
GASP phenotype in the strain carrying a disruption of bglB
encoding the phospho--glucosidase B is consistent with this
possibility. Another possibility is that the bgl operon, besides
allowing the utilization of aryl--glucosides, might provide an
additional function(s) to the organism. For instance, the sig-
naling system involving the BglG-BglF regulators could be
utilized in the regulation of other genetic systems that may
have a role during stationary phase. This is consistent with the
observation that orthologues of BglG and BglF are involved in
the regulation of pathogenicity in Listeria monocytogenes (4).
Though the present studies do not allow quantification of the
GASP effect, the loss of the GASP phenotype in the bgl strain
could be due to the cumulative effect of the loss of both
functions. Until the putative downstream targets are identified,
this is speculative.
In our analyses, we confined ourselves to mutations that are
directly linked to the bgl operon. In four other survivors that
showed a Bgl phenotype (probably siblings), the activating
mutation was in the hns locus. Since H-NS is a global regulator,
it will be difficult to evaluate whether possible fitness effects of
the mutation are due to the activation of the bgl operon or to
a pleiotropic effect of the hns mutation.
If the active bgl allele provides a fitness advantage in the
stationary phase, why is the bgl operon silent in most wild-
type cells? One possibility is that there is a fitness cost
associated with the active allele under specific environmen-
tal conditions. The relative ease with which the operon can
be activated by insertion elements and other mutations pro-
vides a mechanism for the generation of the active allele.
This is reminiscent of the selection for the attenuated alleles
of rpoS as the primary GASP mutations under prolonged
incubation in stationary phase. Our studies show that addi-
tional mutations in the bgl locus enhance this advantage.
Thus, rather than being a “cryptic” genetic element, the bgl
operon appears to be a dynamic component of the bacterial
genome.
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